Division of Infectious Diseases and Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
Division of Immunology and Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
J Infect Dis. 2023 Jun 28;228(1):8-17. doi: 10.1093/infdis/jiad098.
Severe bacterial infections (SBIs) in otherwise healthy children are rare and may represent an underlying impairment of the immune system, including primary immunodeficiency. However, it is unclear whether and how children should be assessed.
We retrospectively analyzed data from hospital records of previously healthy children aged 3 days to 18 years with SBI, including pleuropneumonia, meningitis, and/or sepsis. Patients were diagnosed or immunologically followed up between 1 January 2013 and 31 March 2020.
Among 432 children with SBI, findings could be analyzed in 360. Follow-up data were available for 265 children (74%), of whom 244 (92%) underwent immunological testing. Laboratory abnormalities were found in 51 of 244 patients (21%), with 3 deaths (1%). Fourteen children (6%) had immunodeficiency considered clinically relevant (3 complement deficiencies, 1 autoimmune neutropenia, 10 humoral immunodeficiencies), and 27 (11%) had milder humoral abnormalities or findings suggestive of delayed adaptive immune maturation.
A substantial proportion of children with SBI may benefit from routine immunological testing, revealing (potentially) clinically relevant impaired immune function in 6%-17% of children. The identification of immune abnormalities allows for specific counseling of families and optimization of preventive measures, such as booster vaccinations, to avoid future SBI episodes.
健康儿童中严重细菌感染(SBIs)较为罕见,可能代表免疫系统受损,包括原发性免疫缺陷。然而,目前尚不清楚是否以及如何对儿童进行评估。
我们回顾性分析了 2013 年 1 月 1 日至 2020 年 3 月 31 日期间患有 SBI(包括肺炎、脑膜炎和/或败血症)的 3 天至 18 岁健康儿童的住院记录数据。
在 432 例 SBI 患儿中,360 例患儿的检查结果可进行分析。265 例患儿(74%)有随访数据,其中 244 例(92%)接受了免疫学检查。244 例患儿中有 51 例(21%)存在实验室异常,其中 3 例死亡(1%)。14 例(6%)患儿存在临床相关的免疫缺陷(3 例补体缺陷、1 例自身免疫性中性粒细胞减少症、10 例体液免疫缺陷),27 例(11%)存在较轻的体液异常或提示适应性免疫成熟延迟的发现。
相当一部分 SBI 患儿可能受益于常规免疫学检查,可发现 6%-17%患儿存在(潜在)临床相关免疫功能受损。识别免疫异常可以为患儿家属提供具体的咨询,并优化预防措施,如加强疫苗接种,以避免未来发生 SBI 。